Concourse Financial Group Securities’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 4825 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 5836 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 5826 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 5852 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 5857 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 5796 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 5679 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 5558 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 5360 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 5353 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 5169 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 5177 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 5079 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 5103 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 4972 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 4819 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 4687 |
|